Krystal Biotech

Krish Krishnan, Chairman and CEO

Pittsburgh, PA

(NASDAQ: KRYS)

Virtual Presentation

Krystal Biotech is the leader in redosable gene therapy. We leverage our proprietary technology platform, deep understanding of biology, and in-house manufacturing capabilities to develop potentially life-changing therapies for patients with serious diseases, including rare diseases in skin, lung, and other areas. Krystal’s entrepreneurial spirit, unique approach, and visionary leadership positions us to change the treatment paradigm by delivering the full potential of our platform.

www.krystalbio.com



By using this website you agree to accept our Privacy Policy and Terms & Conditions